CAS: 1270138-40-3; (4-Benzylpiperazin-1-yl)(2-(Isopentylamino)Pyridin-3-yl)Methanone

结构式图片

欧盟法规

C&L通报

上下游产品

2-Chloronicotinoyl chloride 1-(2-chloronicotinoyl)-4-tert-butoxycarbonylpiperazine 17H18ClN3°C17H18ClN3O 1-amino-3-methylbutane

合成工艺路线路线简述

    📜(4-Benzylpiperazin-1-yl)(2-Chloropyridin-3-yl)Methanone 以80的收率获得[2-[(3-甲基丁基)氨基]-3-吡啶基][4-(苯基甲基)-1-哌嗪基]甲酮
    参考文献:Synthesis Of A Neurostimulative Piperazine
    标题:Synthesis Of A Neurostimulative Piperazine
    摘要:该发明描述了一种改进的合成方法,用于合成与烟酸和苄基衍生的哌嗪.产品化合物可用于治疗神经系统疾病.

    海关参考信息

    专利信息


    专利号:US-9481649-B2
    优先权日:2009-08-24
    标题 :Synthesis of a neurostimulative piperazine
    发明人:VENKATRAMAN SRIPATHY; MAHMOOD SYED; MOBELE BINGIDIMI I; LAPINA OLGA; VERCOE KELLIE; LI YING; SALSBURY JONATHAN; MCLAWS MARK
    权利人:NEURALSTEM INC
    摘要:The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.

    专利号:WO-2011028548-A1
    优先权日:2009-08-24
    标 题 :Synthesis of a neurostimulative piperazine

    专利号:US-2016090358-A1
    优先权日:2009-08-24
    标题 :Synthesis of a neurostimulative piperazine

    专利号:US-2013005974-A1
    优先权日:2009-08-24
    标 题 :Synthesis of a neurostimulative piperazine

    专利号:US-9278933-B2
    优先权日:2009-08-24
    标题 :Synthesis of a neurostimulative piperazine

    专利号:EP-2470182-B1
    优先权日:2009-08-24
    标题 :Synthesis of a neurostimulative piperazine

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Zhu S, Shi J, Jin Q, Zhang Y, Zhang R, Chen X, Wang C, Shi T, Li L. Mitochondrial dysfunction following repeated administration of alprazolam causes attenuation of hippocampus-dependent memory consolidation in mice. Aging (Albany NY). 2023 Oct 5;15(19):10428-10452. doi: 10.18632/aging.205087. Epub 2023 Oct 5.
    2: Jolivalt CG, Aghanoori MR, Navarro-Diaz MC, Han MM, Sanchez G, Guernsey L, Quach D, Johe K, Fernyhough P, Calcutt NA. Enhancement of Mitochondrial Function by the Neurogenic Molecule NSI-189 Accompanies Reversal of Peripheral Neuropathy and Memory Impairment in a Rat Model of Type 2 Diabetes. J Diabetes Res. 2022 Jul 4;2022:8566970. doi: 10.1155/2022/8566970.
    3: Johe KK, Kay G, Kumar S, Burdick KE, McIntyre RS, Papakostas GI, Fava M. NSI-189 phosphate, a novel neurogenic compound, selectively benefits moderately depressed patients: A post-hoc analysis of a phase 2 study of major depressive disorder. Ann Clin Psychiatry. 2020 Aug;32(3):182-196. 68(11):2143-2154. doi: 10.2337/db19-0271. Epub 2019 Sep 6.

    合成参考文献


    参考文献:10.1002/jcp.25847
    摘要:Tajiri N, Quach DM, Kaneko Y, Wu S, Lee D, Lam T, Hayama KL, Hazel TG, Johe K, Wu MC, Borlongan CV. NSI‐189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats. Journal Cellular Physiology. 2017 Apr 25;232(10):2731–40. doi: 10.1002/jcp.25847.
    摘要:S61 | UJICCSLIB | Collision Cross Section (CCS) Library from UJI | DOI:10.5281/zenodo.3549476
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知